Tropical Parasitology

REVIEW ARTICLE
Year
: 2014  |  Volume : 4  |  Issue : 1  |  Page : 4--9

Drug resistance in leishmaniasis: Newer developments


Sarita Mohapatra 
 Department of Microbiology, Vardhaman Mahavir Medical College and Safdarjung Hospital, New Delhi, India

Correspondence Address:
Sarita Mohapatra
Room No. 515, 5th Floor, College Building, Vardhaman Mahavir Medical College and Safdarjung Hospital, New Delhi - 110 029
India

Leishmaniasis is a vector borne protozoan disease and it remains a major public health problem world-wide. Lack of an effective vaccine and vector control program makes the chemotherapy as the primary tool for leishmaniasis. Antimonials were used as the first line of treatment for many years. Emergence of resistance against this drug has become a major concern. Literatures and studies published on anti-leishmanial drug resistance, newer drug discovery for leishmanial resistance etc., in PubMed, Medline and Google search and reviewed thoroughly. Various newer drugs have been identified but, are in limited use because of high cost, toxicity, resistance etc., Recently, many newer mechanisms of drug resistance have been identified which may boost in future designing and development of drugs.


How to cite this article:
Mohapatra S. Drug resistance in leishmaniasis: Newer developments.Trop Parasitol 2014;4:4-9


How to cite this URL:
Mohapatra S. Drug resistance in leishmaniasis: Newer developments. Trop Parasitol [serial online] 2014 [cited 2020 Apr 9 ];4:4-9
Available from: http://www.tropicalparasitology.org/article.asp?issn=2229-5070;year=2014;volume=4;issue=1;spage=4;epage=9;aulast=Mohapatra;type=0